Source: Business Wire

Followers on Owler

Annual Revenue

$100K-5.0M

Employees

25-100

CEO

Geert R. Kersten

CEO Approval Rating

90/100

CEL-SCI is a Virginia-based biotechnology company that researches and develops immunotherapies for the treatment of cancer, autoimmune and infectious diseases.

CEL-SCI received $5M in Post-IPO Equity Funding

Followers on Owler